JEFFREY PAUL YANNETTE
Allopathic & Osteopathic Physicians|Pediatrics|Adolescent Medicine LEES SUMMIT, MO NPI 1245239797
Browse related groups: Allopathic & Osteopathic Physicians|Pediatrics|Adolescent Medicine MO Supernus Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$261.86
- Category: General Payments
- Program years: PY2018–2022
- Record count: 17
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $119.66 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $119.66 | 8 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | $83.39 | 6 |
| Tris Pharma Inc | $22.24 | 1 |
| Neos Therapeutics, LP | $14.03 | 1 |
By program year
Records — PY2022 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 893163017 | Neos Therapeutics, LP | $14.03 | 10/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 953030707 | Supernus Pharmaceuticals, Inc. | $14.84 | 01/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 953030709 | Supernus Pharmaceuticals, Inc. | $13.58 | 02/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 953030711 | Supernus Pharmaceuticals, Inc. | $12.79 | 04/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 953030713 | Supernus Pharmaceuticals, Inc. | $13.72 | 05/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 953030715 | Supernus Pharmaceuticals, Inc. | $14.64 | 07/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 953030717 | Supernus Pharmaceuticals, Inc. | $13.82 | 07/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 962088905 | Tris Pharma Inc | $22.24 | 09/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.